20250407_MEDS_Pemanggilan RUPS_31872582_lamp3.pdf

Catatan:
1.    Rapat akan diselenggarakan dengan mengacu pada Peraturan Otoritas Jasa Keuangan Nomor 15/POJK.04/2020
      tentang Rencana dan Penyelenggaraan Rapat Umum Pemegang Saham Perusahaan Terbuka dan Peraturan
      Otoritas Jasa Keuangan Nomor 16/POJK.04/2020 tentang Pelaksanaan Rapat Umum Pemegang Saham
      Perusahaan Terbuka secara Elektronik.
2.    Perseroan tidak mengirimkan undangan tersendiri kepada masing-masing Pemegang saham Perseroan, sehingga
      Pemanggilan ini merupakan undangan resmi bagi seluruh Pemegang Saham Perseroan. Pemanggilan ini
      dapat dilihat juga pada situs web Perseroan (https://www.evoplusmed.com), aplikasi penyelenggaraan
      RUPS secara elektronik atau (“eASY.KSEI”) yang disediakan oleh PT Kustodian Sentral Efek Indonesia
      (“KSEI”) yang dapat diakses melalui situs web KSEI (https://akses.ksei.co.id), dan situs web PT Bursa
      Efek Indonesia (“BEI”).
3.    Pemegang saham yang berhak hadir atau diwakili dalam Rapat adalah para Pemegang Saham Perseroan
      yang namanya tercatat dalam Daftar Pemegang Saham Perseroan pada penutupan jam perdagangan
      Bursa Efek tanggal 27 Maret 2025 pukul 16.00 WIB
4.    Keikutsertaan Pemengang Saham dalam Rapat, dapat dilakukan dengan mekanisme sebagai berikut:
      a. Hadir dalam Rapat secara fisik; atau
      b. Hadir dalam Rapat secara elektronik melalui aplikasi eASY.KSEI.
5.    Pemegang Saham yang tidak dapat hadir dalam Rapat dapat diwakilkan oleh pihak independen yang telah
      ditunjuk oleh Perseroan yaitu perwakilan dari PT Sinartama Gunita selaku Biro Administrasi Efek
      (“BAE”), dengan memberikan kuasa secara konvensional menggunakan format surat kuasa tertulis yang
      dapat diunduh pada situs web Perseroan (https://www.evoplusmed.com). Surat Kuasa wajib diisi dan
      diserahkan kepada BAE paling lambat 1 (satu) hari kerja sebelum tanggal penyelenggaraan Rapat yang
      beralamat di Menara Tekno Lantai 7 Jl. H. Fachrudin No.19 Tanah Abang, Jakarta Pusat.
6.    Pemegang Saham atau Kuasanya yang sah, yang akan menghadiri Rapat secara fisik diminta dengan hormat untuk
      menyerahkan fotokopi Kartu Tanda Penduduk (“KTP”) kepada petugas Rapat, dan wajib membawa Konfirmasi
      Tertulis Untuk Rapat (“KTUR”) yang dapat diperoleh dari Perusahaan Efek atau Bank Kustodian dimana Pemegang
      Saham membuka rekening efeknya.
7.    Bagi Pemegang Saham yang berbentuk badan hukum seperti Perseroan Terbatas, Koperasi, Yayasan, atau Dana
      Pensiun wajib membawa fotokopi anggaran dasar yang terbaru dan lengkap, serta pengesahan atas akta pendirian
      dan persetujuan atas perubahan anggaran dasar yang terakhir dari Departemen Hukum dan Hak Asasi Manusia
      Republik Indonesia berikut susunan pengurus yang terakhir.
8.    Untuk menjamin kelancaran dan tertibnya Rapat, Pemegang Saham atau Kuasanya yang sah diminta dengan
      hormat untuk hadir ditempat Rapat 30 (tiga puluh ) menit sebelum Rapat dimulai.
9.    Bahan-bahan Rapat dan Tata tertib pelaksanaan Rapat dapat diakses melalui situs web Perseroan sejak tanggal
      panggilan ini.
10. Perseroan menghimbau para pemegang saham Perseroan untuk terlebih dahulu membaca Tata Tertib
      Rapat termasuk panduan pelaksanaan Rapat secara elektronik bagi yang akan hadir secara elektronik
      yang tersedia di aplikasi eASY.KSEI. Dengan telah disampaikannya tata tertib tersebut, maka Pemegang Saham
      atau Kuasanya yang sah dianggap telah memahami dan akan mentaati selama pelaksanaan Rapat berlangsung.




                                             Cimahi, 08 April 2025
                                      PT HETZER MEDICAL INDONESIA TBK
                                               Direksi Perseroan

                                                     INVITATION
                                                 TO SHAREHOLDERS
                                          PT HETZER MEDICAL INDONESIA Tbk



The Board of Directors of PT Hetzer Medical Indonesia Tbk (the “Company”) hereby invites the shareholders
of the Company to attend the Annual and Extraordinary General Meeting of Shareholders (the “Meeting”),
which will be held on:
    Day/Date                         : Wednesday, April 30, 2025
    Time                             : 10.00 am Western Indonesia Time until the finish
    Venue                            : Company Office
                                       Kompleks Blue Sky Industrial Kav. 09, Jl. Nanjung No. 02
                                       Kelurahan Leuwigajah, Kecamatan Cimahi Selatan, Kota Cimahi.

The agenda items that will be proposed at the Meeting to be discussed and obtain decisions from the
Company's shareholders are as follows:

A. Annual General Meeting of Shareholders
   1. Approval of the Company's Annual Report regarding the condition and operations of the Company during the 2024
      Financial Year including the Report on the Implementation of the Board of Commissioners' Supervisory Duties
      during the 2024 Financial Year, and Ratification of the Company's Financial Report for the 2024 Financial Year as
      well as granting full release and discharge of responsibility (acquit et de charge) to the Board of Directors and the
      Company's Board of Commissioners for the management and supervision that has been carried out during the
      2024 Financial Year.
      Explanation :
      Based on Article 66 of Law Number 40 of 2007 concerning Limited Liability Companies (UUPT), where the Annual
      Report, Financial Report, and Report on Management and Supervision Tasks must be sought for approval and
      ratification at the Annual General Meeting of Shareholders.

   2. Determination of the Company's Net Profit Use Plan for the 2024 Financial Year
      Explanation :
      Based on articles 70 and 71 paragraph 1 of the Company Law, the Annual General Meeting of Shareholders decides
      the use of the Company's net profit, including determining the amount of allowance for reserves.

   3. Appointment of a Public Accountant for the Financial Year ending December 31, 2025
      Explanation :
      Based on Article 13 of the Financial Services Authority Regulation Number 13/POJK.03/2017 concerning the Use of
      Public Accountant Services and Public Accounting Firms in Financial Services Activities, it is stated that the
      appointment of Public Accountants and/or Public Accounting Firms will provide audit services for annual historical
      financial information. must be decided at the GMS by considering the Board of Commissioners' proposals. If the
      GMS cannot decide on the appointment of a Public Accountant and/or Public Accounting Firm, the GMS can
      delegate the authority to appoint to the Board of Commissioners.

   4. Determination of the Honorarium for Members of the Company's Board of Commissioners and Directors
      Explanation :
      Following Article 96 in conjunction with Article 113 of the Company Law, the honorarium and other allowances for
      members of the Company's Board of Directors and Board of Commissioners are determined by the GMS.

B. Extraordinary General Meeting of Shareholders
   1. Approval of Changes to the Composition of the Company's Management
      Explanation :
      Approval of Changes to the Composition of the Company's Management in connection with the resignation of the
      Company's Board of Commissioners and President Director, to strengthen the Company's organizational structure.

Notes:
1.   The meeting will be held concerning Financial Services Authority Regulation Number 15/POJK.04/2020 concerning
     Planning and Organizing General Meetings of Shareholders of Public Companies and Financial Services Authority
     Regulation Number 16/POJK.04/2020 concerning Implementation of General Meetings of Shareholders of
     Companies Open Electronically.
2.   The Company does not send a separate invitation to each shareholder of the Company, so this invitation is an
     official invitation for all Shareholders. This summons can also be seen on the Company's website
     (https://www.evoplusmed.com), the electronic GMS holding application ("eASY.KSEI") provided by PT Kustodian
     Sentral Efek Indonesia ("KSEI") which can be accessed via the KSEI website (https://akses.ksei.co.id), and the PT
     Bursa Efek Indonesia (“BEI”) website.
3.   Shareholders who have the right to attend or be represented at the Meeting are the Company's Shareholders
     whose names are registered in the Company's Register of Shareholders at the close of Stock Exchange trading
     hours on March 27, 2025 at 16.00 WIB.
4.   Shareholder participation in the Meeting can be carried out using the following mechanism:
     a.      Be physically present at the meeting; or
     b.      Attend the Meeting electronically via the eASY.KSEI application.
5.   Shareholders who are unable to attend the Meeting can be represented by an independent party appointed by
     the Company, namely a representative from PT Sinartama Gunita as the Securities Administration Bureau ("BAE"),
     by providing conventional power of attorney using a written power of attorney format which can be downloaded
     at the Company website (https://www.evoplusmed.com). The Power of Attorney must be filled out and submitted
     to BAE no later than 1 (one) working day before the Meeting date located at Menara Tekno Floor 7 Jl. H. Fachrudin
     No.19 Tanah Abang, Central Jakarta.
6.   Shareholders or their legal proxies, who will physically attend the Meeting are kindly requested to submit a
     photocopy of their Resident Identification Card (“KTP”) to the meeting officer and are required to bring Written
     Confirmation for the Meeting (“KTUR”) which can be obtained from Securities Company or Custodian Bank where
     Shareholders open their securities accounts.
7.   Shareholders in the form of legal entities such as Limited Liability Companies, Cooperatives, Foundations, or
     Pension Funds are required to bring a photocopy of the most recent and complete articles of association, as well
     as ratification of the deed of establishment and approval of the latest amendments to the articles of association
     from the Department of Law and Human Rights. Republic of Indonesia following the latest management structure.
8.   To ensure the smooth and orderly running of the Meeting, Shareholders or their legal proxies are kindly requested
     to be present at the Meeting venue 30 (thirty) minutes before the Meeting starts.
9.   Meeting materials and Meeting Rules and Regulations can be accessed via the Company's website from the date
     of this summons.
10. The Company urges the Company's shareholders to first read the Meeting Rules of Conduct including the
     guidelines for conducting electronic Meetings for those who will attend electronically which are available on the
     eASY.KSEI application. By submitting these rules and regulations, the Shareholders or their legal proxies are
     deemed to have understood and will comply during the Meeting.




                                               Cimahi, April 08, 2025
                                        PT HETZER MEDICAL INDONESIA TBK
                                        Board of Directors of the Company